Banks - Regional
Compare Stocks
2 / 10Stock Comparison
CARE vs NBTB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
CARE vs NBTB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Banks - Regional |
| Market Cap | $580M | $2.36B |
| Revenue (TTM) | $255M | $867M |
| Net Income (TTM) | $31M | $169M |
| Gross Margin | 61.7% | 72.1% |
| Operating Margin | 15.7% | 25.3% |
| Forward P/E | 4.8x | 10.8x |
| Total Debt | $179M | $327M |
| Cash & Equiv. | $105M | $185M |
CARE vs NBTB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 370.7 | +270.7% |
| NBT Bancorp Inc. (NBTB) | 100 | 144.3 | +44.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NBTB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.56
- 111.1% 10Y total return vs NBTB's 102.2%
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
NBTB is the clearest fit if your priority is growth exposure and bank quality.
- Rev growth 10.4%, EPS growth 12.5%
- NIM 3.1% vs CARE's 2.7%
- 10.4% NII/revenue growth vs CARE's 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs CARE's 6.2% | |
| Value | Lower P/E (4.8x vs 10.8x) | |
| Quality / Margins | Efficiency ratio 0.5% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs NBTB's 0.89 | |
| Dividends | 3.2% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +68.4% vs NBTB's +9.3% | |
| Efficiency (ROA) | Efficiency ratio 0.5% vs NBTB's 0.5% |
CARE vs NBTB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs NBTB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 3.4x CARE's $255M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to CARE's 12.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $255M | $867M |
| EBITDAEarnings before interest/tax | $46M | $241M |
| Net IncomeAfter-tax profit | $31M | $169M |
| Free Cash FlowCash after capex | $30M | $225M |
| Gross MarginGross profit ÷ Revenue | +61.7% | +72.1% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +25.3% |
| Net MarginNet income ÷ Revenue | +12.3% | +19.5% |
| FCF MarginFCF ÷ Revenue | +12.5% | +25.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +39.5% |
Valuation Metrics
NBTB leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 13.6x trailing earnings, NBTB trades at a 27% valuation discount to CARE's 18.7x P/E. On an enterprise value basis, NBTB's 10.4x EV/EBITDA is more attractive than CARE's 16.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $580M | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $653M | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | 18.69x | 13.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.76x | 10.83x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.93x |
| EV / EBITDAEnterprise value multiple | 16.33x | 10.38x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.72x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.21x |
| Price / FCFMarket cap ÷ FCF | 18.23x | 10.78x |
Profitability & Efficiency
NBTB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $8 for CARE. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs NBTB's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +9.5% |
| ROA (TTM)Return on assets | +0.7% | +1.1% |
| ROICReturn on invested capital | +5.7% | +7.9% |
| ROCEReturn on capital employed | +1.5% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 0.17x |
| Net DebtTotal debt minus cash | $73M | $142M |
| Cash & Equiv.Liquid assets | $105M | $185M |
| Total DebtShort + long-term debt | $179M | $327M |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 1.05x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,800 today (with dividends reinvested), compared to $12,950 for NBTB. Over the past 12 months, CARE leads with a +68.4% total return vs NBTB's +9.3%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.8% vs NBTB's 15.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +34.7% | +9.6% |
| 1-Year ReturnPast 12 months | +68.4% | +9.3% |
| 3-Year ReturnCumulative with dividends | +94.6% | +54.5% |
| 5-Year ReturnCumulative with dividends | +88.0% | +29.5% |
| 10-Year ReturnCumulative with dividends | +111.1% | +102.2% |
| CAGR (3Y)Annualised 3-year return | +24.8% | +15.6% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NBTB's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 0.89x |
| 52-Week HighHighest price in past year | $26.41 | $46.92 |
| 52-Week LowLowest price in past year | $15.37 | $39.20 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 75.2 | 54.2 |
| Avg Volume (50D)Average daily shares traded | 273K | 234K |
Analyst Outlook
NBTB leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CARE as "Buy" and NBTB as "Hold". Consensus price targets imply 3.2% upside for CARE (target: $27) vs 1.8% for NBTB (target: $46). NBTB is the only dividend payer here at 3.16% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $46.00 |
| # AnalystsCovering analysts | 4 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% |
| Dividend StreakConsecutive years of raises | 0 | 12 |
| Dividend / ShareAnnual DPS | — | $1.43 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +0.4% |
NBTB leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CARE leads in 2 (Total Returns, Risk & Volatility).
CARE vs NBTB: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CARE or NBTB a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 6x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NBTB?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 6x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CARE or NBTB?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +88. 0%, compared to +29. 5% for NBT Bancorp Inc. (NBTB). Over 10 years, the gap is even starker: CARE returned +111. 1% versus NBTB's +102. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NBTB?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus NBT Bancorp Inc. 's 0. 89β — meaning NBTB is approximately 58% more volatile than CARE relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NBTB?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NBTB?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NBTB more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 4. 8x forward P/E versus 10. 8x for NBT Bancorp Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 2% to $27. 00.
08Which pays a better dividend — CARE or NBTB?
In this comparison, NBTB (3.
2% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NBTB better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 3. 2% yield, +102. 2% 10Y return). Both have compounded well over 10 years (NBTB: +102. 2%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NBTB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CARE is a small-cap quality compounder stock; NBTB is a small-cap deep-value stock. NBTB pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.